Humira

Identification

Brand Name

Humira

Product Description

Humira is a prescription tumor necrosis factor (TNF) blocker available in multiple countries including the United States, Canada, the EU, Italy, and Indonesia. It was first marketed in 2002. It is available in a Subcutaneous Injection. It contains one active ingredient: Adalimumab. Adalimumab is a medication used to treat a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.

Ingredients

Drug	Salt
Adalimumab	Not Available

Pharmacology

Indications

Management of Ankylosing Spondylitis (AS) Prescription

Management of Moderate to Severe Rheumatoid Arthritis Prescription

Management of Polyarticular Juvenile Idiopathic Arthritis Prescription

Management of Psoriatic Arthritis Prescription

Treatment of Hidradenitis Suppurativa (HS) Prescription

Treatment of Moderate to Severe Chronic Plaque Psoriasis Prescription

Treatment of Moderately to Severely Active Crohn's Disease Prescription

Treatment of Moderately to Severely Active Ulcerative Colitis Prescription

Treatment of Non-infectious Intermediate, Posterior and Panuveitis Prescription

Treatment of Pyoderma Gangrenosum Off Label

Used in combination to manage Moderate to Severe Rheumatoid Arthritis in a regimen Prescription

Used in combination to manage Moderately to Severely Active Rheumatoid Arthritis in a regimen Prescription

Used in combination to manage Polyarticular Juvenile Idiopathic Arthritis in a regimen Prescription

Used in combination to treat Type 1 Diabetes Mellitus in a regimen Prescription

Products

Dosage	Strength	Route	Labeller	Marketing Start	Marketing End	NDC Code
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/018
Injection, solution	80 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	-	EU/1/03/256/027
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/006
Injection, solution	40 mg/0.8ml	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/001
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/010
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/013
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/016
Injection, solution	80 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	-	EU/1/03/256/021
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/014
Injection, solution	20 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	2021-07-27	EU/1/03/256/022
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/008
Injection, solution	80 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	-	EU/1/03/256/020
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/015
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	2021-07-27	EU/1/03/256/023
Injection, solution	80 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	2021-07-27	EU/1/03/256/026
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/005
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/004
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/003
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/017
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/012
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/007
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/019
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/002
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	2021-07-27	EU/1/03/256/025
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2021-01-27	2021-07-27	EU/1/03/256/024
Injection, solution	40 mg	Subcutaneous	Abb Vie Deutschland Gmb H Co. Kg	2016-09-08	-	EU/1/03/256/009
Injection, solution	40 mg/0.8mL	Subcutaneous	AbbVie Inc.	2002-12-30	2015-11-30	0074-3797
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946096
Injection, solution	80 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2019-09-25	-	035946262
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2015-10-22	-	035946122
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2016-10-04	-	035946173
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946060
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946021
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946045
Injection, solution	40 MG/0.8ML	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946019
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2015-10-22	-	035946134
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2015-10-22	-	035946110
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946108
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946084
Injection, solution	20 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2018-09-08	-	035946211
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2019-01-26	-	035946235
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2016-10-04	-	035946159
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946058
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946072
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2019-01-26	-	035946247
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2019-01-26	-	035946223
Injection, solution	80 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2017-11-18	-	035946209
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2016-10-04	-	035946161
Injection, solution	80 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2017-11-18	-	035946197
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2016-10-04	-	035946185
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2015-10-22	-	035946146
Injection, solution	40 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2014-07-08	-	035946033
Injection, solution	80 MG	Parenteral; Subcutaneous	Abbvie Deutschland Gmbh & Co. Kg	2019-01-26	-	035946250
Solution	20 mg / 0.2 mL	Subcutaneous	Abbvie	2020-08-18	-	02474263
Solution	10 mg / 0.1 mL	Subcutaneous	Abbvie	-	-	02474255
Solution	80 mg / 0.8 mL	Subcutaneous	Abbvie	-	-	02474220
Solution	40 mg / 0.8 mL	Subcutaneous	Abbvie	2004-09-24	-	02258595
Solution	80 mg / 0.8 mL	Subcutaneous	Abbvie	-	-	02466872
Solution	40 mg / 0.4 mL	Subcutaneous	Abbvie	2016-11-14	-	02458349
Solution	40 mg / 0.4 mL	Subcutaneous	Abbvie	2016-11-14	-	02458357
Solution	80.000 mg	Subcutaneous		2003-05-03	-	195M2003:1
Injection, solution	40 MG	Parenteral		2021-04-01	-	12449716
Injection, solution	40 MG/0.4ML	Parenteral		2021-04-01	-	14062364
Injection, solution	40 MG/0.4ML	Parenteral		2021-04-01	-	14140012
Injection, solution	40 MG/0.4ML	Parenteral		2021-04-01	-	12472589
Injection, solution	40 MG/0.4ML	Parenteral		2021-04-01	-	12589914
Injection, solution	40 MG/0.4ML	Parenteral		2021-04-01	-	14168660
Injection, solution	40 MG	Parenteral		2021-04-01	-	12471414
Injection, solution	40 MG/0.4ML	Parenteral		2021-04-01	-	14139983
Injection, solution	40 MG	Parenteral		2021-04-01	-	12562068
Injection	40 MG/0.4ML	Subcutaneous	Abbott Indonesia	2018-11-06	2023-11-06	DKI1882100643B2
Injection	40 MG/0.4ML	Subcutaneous	Abbott Indonesia	2018-10-17	2023-10-17	DKI1882100643B1
Injection		Subcutaneous	Abbott Indonesia	2014-04-01	2019-10-30	DKI0582100643A1
Injection		Subcutaneous	Abbott Indonesia	2018-03-19	2024-06-12	DKI0582100643A2

Interactions

Drug Interaction Search

Warning: If no interactions are found between two drugs, it does not necessarily mean that no interactions exist. Always consult with a healthcare professional.

This interaction checker is limited to 5 drugs at once, available for educational and information purposes only. It is not representative of the full commercial version, which integrates into your products. Learn more

Add drug to check for interactions with this medication

Add up to 4 more drugs.

You've reached the maximum drug limit. Remove a drug to add a new one.

Adalimumab [Humira]

Check Interactions

ClearLoad Example

All Drug Interactions

Show all

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drug	Interaction
Integrate drug-drug interactions in your software
Abatacept	The risk or severity of infection can be increased when Adalimumab is combined with Abatacept.
Abciximab	The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.
Abemaciclib	The metabolism of Abemaciclib can be increased when combined with Adalimumab.
Abrocitinib	The metabolism of Abrocitinib can be increased when combined with Adalimumab.
Acalabrutinib	The metabolism of Acalabrutinib can be increased when combined with Adalimumab.
Acebutolol	The metabolism of Acebutolol can be increased when combined with Adalimumab.
Acenocoumarol	The metabolism of Acenocoumarol can be increased when combined with Adalimumab.
Acetaminophen	The metabolism of Acetaminophen can be increased when combined with Adalimumab.
Acetohexamide	The metabolism of Acetohexamide can be increased when combined with Adalimumab.
Acetylsalicylic acid	The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more